
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Table of Contents
almost 23 years ago
Predicting Success: A Pipeline Reportalmost 23 years ago
Interferons: A Family Business





